Our cell culture platform provides end-to-end capabilities for veterinary applications — from cell line development for vaccine production to process scale-up for animal biologics manufacturing.
Our BSL-2 cell culture suites support veterinary vaccine production, animal biologics manufacturing and advanced cell-based research.
Four core capabilities that power our end-to-end cell culture platform for veterinary applications.
Development and characterisation of cell lines for veterinary vaccine production, including Vero, MDCK, CEF and other animal-origin cell systems.
Stable cell line generation and single-cell cloning for consistent, high-yielding production of veterinary biologics and diagnostic reagents.
Serum-free and chemically defined media development tailored to veterinary cell culture requirements, maximising cell growth and product yield.
Systematic scale-up from flask to bioreactor for veterinary biologics production, with full documentation meeting veterinary GMP requirements.
Our cell culture expertise serves the full breadth of the veterinary and animal health industry.
Industrial-scale microbial fermentation for veterinary biologicals, animal probiotics and feed additives.
Learn moreRational design and directed evolution of proteins for veterinary diagnostics, therapeutics and animal health applications.
Learn moreIntegrated discovery platform for veterinary pharmaceuticals — from target validation through lead optimisation.
Learn moreHigh-yield production of enzymes for animal feed, veterinary diagnostics and livestock health applications.
Learn moreFrom cell line development to bioreactor scale-up, tell us about your veterinary biologics project and we'll design a path forward.
Contact Our Team